Dopaminergic synapse pathway (DA pathway)

The dopaminergic synapse pathway is a fundamental neurotransmission system in the brain that regulates essential functions such as motor coordination, reward-seeking behavior, and cognitive processes (KEGG: hsa04728). Signaling begins with the synthesis of dopamine from tyrosine and its subsequent release from presynaptic neurons into the synaptic cleft. Upon release, dopamine binds to two main classes of G protein-coupled receptors: D1-like receptors (D1 and D5) which generally stimulate adenylate cyclase, and D2-like receptors (D2, D3, and D4) which typically inhibit it (StatPearls: Dopamine). Termination of the signal is primarily achieved through reuptake by the dopamine transporter (DAT) or degradation by enzymes like monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT). Dysfunctions in this pathway are strongly linked to neurodegenerative and psychiatric conditions, including Parkinson’s disease, schizophrenia, and ADHD (PubMed: 28983515). Therapeutic strategies often focus on restoring dopamine balance using precursors like levodopa, receptor modulators, or reuptake inhibitors.

Other names

Dopamine signaling pathwayDopaminergic neurotransmissionKEGG: hsa04728

Drugs targeting this pathway modulate the concentration or activity of dopamine by increasing synthesis (precursors), inhibiting degradation (MAO/COMT inhibitors), blocking reuptake (DAT inhibitors), or acting as agonists/antagonists at D1-like and D2-like receptors to restore physiological signaling (StatPearls: Dopamine).